TabletsClinical Overview
Acarbose (50 mg) is a microbial pseudotetrasaccharide competitive alpha-glucosidase and pancreatic alpha-amylase inhibitor on the WHO Model List of Essential Medicines. It retards digestion of complex starches and sucrose in the upper jejunum, shifting carbohydrate digestion to the lower bowel and blunting postprandial glycemic excursions. Indicated for type 2 diabetes mellitus.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with the exact first bite of each main meal with water.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Flatulence, diarrhea, abdominal pain, bloating. Rare/Severe: Elevation of liver transaminases, hepatitis.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Treat hypoglycemia exclusively with oral dextrose/glucose, not sucrose or candy. Contraindicated in inflammatory bowel disease, colonic ulceration, and intestinal obstruction.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered endocrinologist, diabetologist, or qualified physician before initiating, adjusting dosages of, or substituting any antidiabetic or hormonal medication.
Acarbose Tablets 25 mg
Acarbose (50 mg) is a microbial pseudotetrasaccharide competitive alpha-glucosidase and pancreatic alpha-amylase inhibitor on the WHO Model List of Essential Medicines. It retards digestion of complex starches and sucrose in the upper jejunum, shifting carbohydrate digestion to the lower bowel and blunting postprandial glycemic excursions. Indicated for type 2 diabetes mellitus.
Acarbose 50mg + Metformin Hydrochloride 500mg Tablets
Metformin Hydrochloride is the foundational first-line biguanide oral antihyperglycemic agent on the WHO Model List of Essential Medicines. It activates AMP-activated protein kinase (AMPK) in the liver, suppressing mitochondrial respiratory chain complex I, thereby potently inhibiting hepatic gluconeogenesis and glycogenolysis, while stimulating peripheral glucose uptake into skeletal muscle and delaying intestinal glucose absorption. Does not stimulate beta-cell insulin secretion, having zero intrinsic hypoglycemia risk and promoting weight neutrality or mild weight loss. Indicated as the initial pharmacological drug of choice for type 2 diabetes mellitus in adults and children aged 10 and older, and off-label in polycystic ovary syndrome (PCOS).